CEO: L. Daniel Browne

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.


Key numbers

Market Capitalization:742033180
Shares Outstanding: 45108400
Float: 39068927
Next Earning Date:2020-02-25
TTm EPS: -3.7868
TTm Dividend Rate:
200 days moving average:13.56
50 days moving average: 15.46
One day percent Change: 0.55



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,